You may also like
Effects of Haemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass Induced Immunosuppression
The aim of our present study was to evaluate the ability of antioxidant therapy with mannitol or haemofiltration during CPB to modulate this immunosuppression after CPB.
1 min read
Where Perfusion Meets Purpose: Reflections from the 2025 Sanibel Symposium
The 14th annual Sanibel Symposium once again brought together the brightest minds in cardiac and perfusion care for an unforgettable week of learning, networking, and innovation. Held May 7–10, 2025, at the breathtaking Hyatt Regency Coconut Point Resort in Bonita Springs, Florida, the event blended academic excellence with a refreshing sense of camaraderie. We caught up with two key team members, Mia Bennett and Bridgett Keeley, to hear about their experiences behind the scenes and their hopes for next year.
4 min read
Perfusion Partners Settles Patent Dispute With Cytomedix
Cytomedix (AMEX:GTF - News) today announced that Perfusion Partners and Associates Inc. (PPAI), based in Fort Meyers, Florida, and its affiliate organization, Transcorporeal Inc., have settled a patent dispute with Cytomedix for its platelet-derived therapies for treating wounds and other damaged tissue.
1 min read